Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia

NCT00931190 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 195

Last updated 2009-09-15

No results posted yet for this study

Summary

The objectives are to evaluate the effectiveness of treatment of cervical intraepithelial neoplasia (CIN) by loop electrosurgical excision procedure using persistence of human papillomavirus (HPV) as outcome, and to perform a long-term follow-up on the ability of HPV testing, as compared to cytology, to predict recurrence of high-grade CIN.

Conditions

  • Human Papillomavirus Infection
  • Cervical Intraepithelial Neoplasia

Sponsors & Collaborators

  • Swedish Cancer Society

    collaborator OTHER
  • Lund University

    lead OTHER

Principal Investigators

  • Anna Söderlund Strand, PhD · Dept. medical microbiology, Malmö university hospital, Malmö, Sweden

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-02-28
Completion
2005-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00931190 on ClinicalTrials.gov